Blossomhill Therapeutics Patents – Insights & Stats (Updated 2023)
Blossomhill Therapeutics has a total of 40 patents globally, out of which 1 has been granted. Of these 40 patents, more than 90% patents are active. Taiwan is where Blossomhill…
Blossomhill Therapeutics has a total of 40 patents globally, out of which 1 has been granted. Of these 40 patents, more than 90% patents are active. Taiwan is where Blossomhill…
Aivita Biomedical has a total of 58 patents globally, out of which 7 have been granted. Of these 58 patents, more than 79% patents are active. United States of America…
Agenovir has a total of 71 patents globally, out of which 1 has been granted. Of these 71 patents, more than 5% patents are active. United States of America is…
Scorpion Therapeutics has a total of 42 patents globally, out of which none have been granted. Of these 42 patents, more than 80% patents are active. The United States of…
Theradaptive has a total of 48 patents globally, out of which 3 have been granted. Of these 48 patents, more than 85% patents are active. The United States of America…
Roswell Biotechnologies has a total of 119 patents globally, out of which 18 have been granted. Of these 119 patents, more than 67% patents are active. Europe is where Roswell…
Lyndra Therapeutics has a total of 101 patents globally, out of which 15 have been granted. Of these 101 patents, more than 96% patents are active. Japan is where Lyndra…
Dragonfly Therapeutics has a total of 683 patents globally, out of which 20 have been granted. Of these 683 patents, more than 87% patents are active. The United States of…
Acrotech Biopharma has a total of 32 patents globally, out of which 26 have been granted. Of these 32 patents, more than 87% patents are active. The United States of…
Vyripharm Enterprises has a total of 28 patents globally, out of which 8 have been granted. Of these 28 patents, more than 82% patents are active. United States of America…
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.
